SUMMARYObjective: The current study assessed the efficacy of three current bleaching methods.Methods: Seventy-five healthy subjects (45♀; 30♂) with anterior teeth, having a Vita Shade score of A2 or darker, participated in the study. The subjects were randomly assigned to one of three treatment groups: Group A: home-bleaching (Illumine Home, 10% carbamide peroxide, trays, overnight, for two weeks), Group B: inoffice bleaching (Illumine Office, 15% hydrogen peroxide, trays for 45 minutes, three times over three weeks), Group C: Whitestrips (strips, twice a day, 30 minutes each for two weeks).Following the screening visit, three weeks prior to the baseline examination, all subjects received a dental prophylaxis.
Clinical RelevanceThe efficacy of vital bleaching depends on the two aspects-viz, bleaching agent and the bleaching method. Results from this in vivo study show that 10% carbamide peroxide home-bleaching and 15% hydrogen peroxide in-office bleaching were more effective than a 6% hydrogen peroxide home-bleaching over-the-counter product up to three months after completion of the bleaching treatment.
M Bizhang • Y-HP Chun • K Damerau P Singh • WH-M Raab • S ZimmerThe color of the teeth was determined using a colorimeter (ShadeEye NCC) and a custom-made stent at baseline (E 0 ), immediately after completion of the bleaching (E 3 ) and three months after treatment (E 4 ). All subjects received oral hygiene instructions and a toothbrush and toothpaste for oral home care during the study period.The change of tooth color was determined for each treatment regimen between baseline and E 3 and baseline and E 4 and was statistically analyzed performing the Kruskal Wallis test and the Mann-Whitney-U test. The significance level was set at p<0.01.Results: The dropout rate was 0%. Mean (SD) ∆E* (overall color change) from baseline to immediately after treatment was 6.57 (2.13) for Group A, 5.77(1.72) for Group B and 3.58 (1.57) for Group C. The mean (SD) tooth color change from baseline to three months after treatment ∆E* was: 4.98(1.34) for Group A, 4.59 (1.42) for Group B and 2.99 (1.39) for Group C. Significant differences were found between home bleaching and Whitestrips, as well as between in-office bleaching and Whitestrips, but not between homebleaching and in-office bleaching during the same time.Conclusion: Using an objective color measurement device, home bleaching and in-office bleaching were found to be superior to Whitestrips. Home bleaching and in-office bleaching were equally efficient for bleaching teeth and maintaining the results for up to three months.
The purpose of the present investigation was to identify the most frequent therapies and, in particular, the prescription patterns for occlusal splints for the management of craniomandibular disorders (CMDs) used by German general dentists and specialists. Additionally, the knowledge and opinion of the practising dentists were examined. All active members of the statutory dental insurance providers of the German North Rhine (n = 5,500) and the Westphalia-Lippe area (n = 4,984) were surveyed with a questionnaire by mail. Results indicated that occlusal splints were the first-choice therapy followed by physiotherapy and occlusal equilibration. In the preceding year, both general dentists and specialists made 30 occlusal splints on average. With regard to high-quality evidence-based recommendations, some statistically significant discrepancies between general dentists and specialists were detected. On the basis of the present data, it seems useful to consider intensifying the topic of CMDs and orofacial pain in future undergraduate dental curricula and in postgraduate training.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.